Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 62 (3), 251-8

Flupirtine, a Re-Discovered Drug, Revisited

Affiliations
Review

Flupirtine, a Re-Discovered Drug, Revisited

Istvan Szelenyi. Inflamm Res.

Abstract

Flupirtine was developed long before K(V)7 (KCNQ) channels were known. However, it was clear from the beginning that flupirtine is neither an opioid nor a nonsteroidal anti-inflammatory analgesic. Its unique muscle relaxing activity was discovered by serendipity. In the meantime, broad and intensive research has resulted in a partial clarification of its mode of action. Flupirtine is the first therapeutically used K(V)7 channel activator with additional GABA(A)ergic mechanisms and thus the first representative of a novel class of analgesics. The presently accepted main mode of its action, potassium K(V)7 (KCNQ) channel activation, opens a series of further therapeutic possibilities. One of them has now been realized: its back-up compound, the bioisostere retigabine, has been approved for the treatment of epilepsy.

Similar articles

See all similar articles

Cited by 13 PubMed Central articles

See all "Cited by" articles

References

    1. Postgrad Med J. 1987;63 Suppl 3:57-60 - PubMed
    1. Postgrad Med J. 1987;63 Suppl 3:49-55 - PubMed
    1. Am J Pathol. 2008 Nov;173(5):1496-507 - PubMed
    1. Pain. 2011 Apr;152(4):742-54 - PubMed
    1. Eur J Pharmacol. 1993 Jan 12;230(2):203-7 - PubMed

MeSH terms

LinkOut - more resources

Feedback